134 related articles for article (PubMed ID: 7025545)
41. Mineralocorticoid hypertension.
Stewart PM
Lancet; 1999 Apr; 353(9161):1341-7. PubMed ID: 10218547
[TBL] [Abstract][Full Text] [Related]
42. Plasma aldosterone response to ACTH in primary aldosteronism and in patients with low renin hypertension.
Kem DC; Weinberger MH; Higgins JR; Kramer NJ; Gomez-Sanchez C; Holland OB
J Clin Endocrinol Metab; 1978 Apr; 46(4):552-60. PubMed ID: 225341
[TBL] [Abstract][Full Text] [Related]
43. New genetic insights in familial hyperaldosteronism.
Jackson RV; Lafferty A; Torpy DJ; Stratakis C
Ann N Y Acad Sci; 2002 Sep; 970():77-88. PubMed ID: 12381543
[TBL] [Abstract][Full Text] [Related]
44. [Hypertension and mineralocorticoids. Usefulness of renin and aldosterone measurements].
Fardella CE; Montero J; Mosso L
Rev Med Chil; 1999 May; 127(5):604-10. PubMed ID: 10451632
[TBL] [Abstract][Full Text] [Related]
45. Assessment of 11beta-hydroxylase activity with plasma corticosterone, deoxycorticosterone, cortisol, and deoxycortisol: role of ACTH and angiotensin.
Ganguly A; Meikle AW; Tyler FH; West CD
J Clin Endocrinol Metab; 1977 Mar; 44(3):560-8. PubMed ID: 190262
[TBL] [Abstract][Full Text] [Related]
46. A new variant of 17 alpha-hydroxylase deficiency with hyperaldosteronism in two Japanese sisters.
Monno S; Takasu N
Endocrinol Jpn; 1989 Apr; 36(2):315-23. PubMed ID: 2550210
[TBL] [Abstract][Full Text] [Related]
47. [The renin-angiotensin-aldosterone system. Disorders and methods of clinical research].
Vallotton MB; Scholer D; Muller AF
Schweiz Med Wochenschr; 1970 Oct; 100(40):1666-71. PubMed ID: 4335209
[No Abstract] [Full Text] [Related]
48. 10. Hypertension. A comparison of the effects of angiotensin II infusion and variations in salt intake on plasma aldosterone levels in normal subjects, patients with essential hypertension and patients with hyperaldosteronism.
Zoccali C; Usherwood T; Brown JJ; Lever AF; Robertson JI; Fraser R
J Steroid Biochem; 1983 Jul; 19(1A):327-31. PubMed ID: 6310234
[TBL] [Abstract][Full Text] [Related]
49. Syndromes that Mimic an Excess of Mineralocorticoids.
Sabbadin C; Armanini D
High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):231-5. PubMed ID: 27251484
[TBL] [Abstract][Full Text] [Related]
50. Differentiation between subtypes of primary hyperaldosteronism by multiple steroid measurement after dexamethasone administration.
Pellnitz W; Schöneshöfer M; Oelkers W
Klin Wochenschr; 1978 Sep; 56(17):855-8. PubMed ID: 713414
[TBL] [Abstract][Full Text] [Related]
51. Mineralocorticoid hypertension due to hyperaldosteronism and hyperdeoxycorticosteronism.
Biglieri EG; Kater CE; Arteaga EA
J Hypertens Suppl; 1986 Dec; 4(5):S61-5. PubMed ID: 3553487
[TBL] [Abstract][Full Text] [Related]
52. Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension.
Gordon RD; Gomez-Sanchez CE; Hamlet SM; Tunny TJ; Klemm SA
J Hypertens Suppl; 1987 Dec; 5(5):S103-6. PubMed ID: 2832571
[TBL] [Abstract][Full Text] [Related]
53. Selection of patients for surgery for primary aldosteronism.
Plouin PF; Rossignol P; Amar L
Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):522-5. PubMed ID: 18307754
[TBL] [Abstract][Full Text] [Related]
54. Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone.
Sutherland DJ; Ruse JL; Laidlaw JC
Can Med Assoc J; 1966 Nov; 95(22):1109-19. PubMed ID: 4288576
[TBL] [Abstract][Full Text] [Related]
55. Plasma renin activity and urinary aldosterone in Cushing's syndrome.
Mantero F; Armanini D; Boscaro M
Horm Metab Res; 1978 Jan; 10(1):65-71. PubMed ID: 204567
[TBL] [Abstract][Full Text] [Related]
56. [A study on the mechanism of aldosterone secretion in low-renin essential hypertension (author's transl)].
Haruyama K
Nihon Naibunpi Gakkai Zasshi; 1979 Oct; 55(10):1322-40. PubMed ID: 229001
[No Abstract] [Full Text] [Related]
57. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
58. [High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension].
Mosso L; Fardella C; Montero J; Rojas P; Sánchez O; Rojas V; Rojas A; Huete A; Soto J; Foradori A
Rev Med Chil; 1999 Jul; 127(7):800-6. PubMed ID: 10668287
[TBL] [Abstract][Full Text] [Related]
59. Treatment of familial hyperaldosteronism type I: only partial suppression of adrenocorticotropin required to correct hypertension.
Stowasser M; Bachmann AW; Huggard PR; Rossetti TR; Gordon RD
J Clin Endocrinol Metab; 2000 Sep; 85(9):3313-8. PubMed ID: 10999827
[TBL] [Abstract][Full Text] [Related]
60. [Hyperaldosteronism suppressible by glucocorticoids. An unusual cause of familial hypertension].
Pasquet A; Thibaut A; Maiter D; De Plaen JF
Ann Endocrinol (Paris); 1995; 56(2):149-53. PubMed ID: 7755343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
